Cover Image

Status of the VEGF expression in Indian gastric cancer patients.

KESAVAN BALARAMAN

Abstract


Department of Surgical Gastroenterology and Proctology,
MADRAS MEDICAL COLLEGE AND GOVERNMENT GENERAL HOSPITAL


Full Text:

PDF

References


Ferlay J, Shin HR, Bray F, Forman

D, Mathers C, Parkin DM. Peter

Boyle, Bernard Levin. GLOBOCAN

, Cancer Incidence and

Mortality Worldwide: IARC Cancer-

Base No. 10. Lyon, France: International

Agency for Research on Cancer.

Available from: http: //

www.globocan.iarc.fr. World Cancer

Report, 2008 IARC; 2008 .

Mohandas KM, Jagannath P.

Epidemiology of digestive tract

cancers in India. VI. Projected burden

in the new millennium and the

need for primary prevention. Indian

J Gastroenterol. 2000;19:748.

Correa P, Haenszel W, Cuello C,

Tannenbaum S, Archer M: A model

of gastric cancer epidemiology.

Lancet 1975, 2 (7924): 58-60.26.

Gao L, Nieters A, Brenner H: Metaanalysis:

tumorinvasionrelated genetic

polymorphisms and gastric

cancer susceptibility. Aliment PharmacolTher

, 28 (5): 565-573.

Folkman J : How is blood vessel

growth regulated in normal and

neoplastic tissue? G.H.A. Clowes-

Memorial Award Lecture. Cancer

Res 46: 467-473, 1986.

Tanigawa N, Amaya H, Matsumura

M and Shimomatsuya T: Association

of tumor vasculature withtumor

progression and overall survival

of patients with non-early gastric

carcinomas. Br J Cancer 75:

-571, 1997.

Folkman J. In: DeVita VT Jr, Hellman

S, Rosenberg SA, Eds. Cancer: Principles

& Practice of Oncology. Vol 2. 7th

Ed. Philadelphia, PA: Lippincott Williams

& Wilkins; 2005:2865-2882.

Hanrahan V, Currie MJ, Gunningham

SP, et al. The angiogenic switch for vascular

endothelial growth factor (VEGF) -

A, VEGF-B, VEGF-C, and VEGF-D in the

adenoma-carcinoma sequence during

colorectal cancer progression J

Pathol. 2003;200:183-194.

Tannock IF, Hill RP, Bristow RG, et al,

Eds. Basic Science of Oncology. 4th Ed.

New York, NY: McGraw-Hill; 2005:231-

Fontanini G, Vignati S, Boldrini L, et al.

Vascular endothelial growth factor is associated

with neovascularization and influences

the progression of non-small cell

lung carcinoma. Clin Cancer

Res. 1997;3:861-865.

MAEDA K., CHUNG Y., OGAWA Y.,

TAKATSUKA S., KANG S. M.,

OGAWA M., SAWADA T., SOWA M., Pro

g n o s t i c v a l u e o f v a s -

clar endothelial growth factor expression i

n gastriccarcinoma, Cancer, 1996, 77

(5):858–863.

IKEGUCHIM.,

OKAS.,SAITOH.,KONDOA.,TSUJI

TANIS.MAETAM.,KAIBARAN.,Theexpres

sion of thymidine phosphorylase

and its correlation with angiogenesis

in gastric

adenocarcinoma, Anticancer Res, 19

, 19(5B):4001–4005.

GAO Z. L., ZHANG C., DU G. Y.,

LU Z. J., Clinical significance

of changes in tumor markers,

extracellular matrix MMP-9

and VEGF in p a t i e n t s

with gastric carcinoma,Hepatogastro

enterology, 2007, 54(77):1591–1595.

BOKU N., OHTSU A., NAGASHIMA

F., SHIRAO K., KOIZUMI W.

Relationship between expression of

vascular endothelial growth factor in

tumor tissue from gastric cancers and

chemotherapy effects: comparison

between S-1 alone and the combination

of S-1 plus CDDP, Jpn J ClinOncol,

, 37 (7): 509–514.

WANG G., DONG Z., XU G.,

YANG Z., SHOU C., WANG N., LIU

T., The effect of antibody against vascular

endothelial growth factor on tumor

growth and metastasis, J Cancer

Res ClinOncol, 1998, 124 (11): 615–

ISHIKAWA M., KITAYAMA J., KAZAMA

S., NAGAWA H., Expression of

vascular endothelial growth factor

(VEGF) -Cain proprietary specimens

and metastatic foci of regional lymph

nodes in submucosal gastric carcinoma,

World JSurgOncol, 2005, 3 (1):


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University